← Insider buys
TCRR

Tcr2 Therapeutics Inc.

Director Patrick Baeuerle sold $1.8M of Tcr2 Therapeutics Inc.

Sold$1,796,418
$15.36Price
116,929Shares
−25%Stake

What TCRR did after the filing

Prices for TCRR after this filing aren't in yet.

Traded Fri, Dec 20. Filed Thu, Dec 26, 12:30 PM ET, during the session. Not investment advice.